These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18040909)

  • 1. [Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
    Lay-Son Rivas L; Pizarro Segura J; Meza Flores R
    Neurologia; 2007 Dec; 22(10):915-6. PubMed ID: 18040909
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic effect of levetiracetam on posthypoxic myoclonus: difficult weaning from mechanical ventilation.
    Muslu B; Kilci O; Horasanli E; Dikmen B
    Clin Neuropharmacol; 2009; 32(4):236. PubMed ID: 19644236
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
    Venot M; Weiss N; Espinoza S; Imbert A; Tadie JM; Fagon JY; Guerot E; Diehl JL
    Intensive Care Med; 2011 Jan; 37(1):177-9. PubMed ID: 20871977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of levetiracetam in the treatment of two cases of hypoxic encephalopathy with myoclonic status].
    de Gea-García JH; Villegas I; Sánchez Cámara S; Martínez Fresneda M
    Med Intensiva; 2011; 35(6):393-4. PubMed ID: 21296455
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report.
    Božić K; Gebauer-Bukurov K; Sakalaš L; Divjak I; Ješić A
    Vojnosanit Pregl; 2014 May; 71(5):515-9. PubMed ID: 26137720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.
    Orsucci D; Ienco EC; Rocchi A; Siciliano G; Mancuso M; Bonuccelli U
    Mov Disord; 2013 Sep; 28(10):1465. PubMed ID: 23495097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Favorable course of Lance-Adams postanoxic action myoclonus].
    Errguig L; Benomar A; Messouak W; Regragui W; Benabdejlil M; Yahyaoui M; Chkili T
    Rev Neurol (Paris); 2003 Jan; 159(1):74-6. PubMed ID: 12618657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of encephalopathy and myoclonus with levetiracetam in a case of subacute sclerosing panencephalitis.
    Becker D; Patel A; Abou-Khalil BW; Pina-Garza JE
    J Child Neurol; 2009 Jun; 24(6):763-7. PubMed ID: 19151368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postanoxic myoclonus: two case presentations and review of medical management.
    Budhram A; Lipson D; Nesathurai S; Harvey D; Rathbone MP
    Arch Phys Med Rehabil; 2014 Mar; 95(3):588-90. PubMed ID: 24060492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease.
    Imperiale D; Bortolotto S; Cucatto A; Schiffer P; Cassano D; Buffa C
    Eur Neurol; 2003; 49(3):189-90. PubMed ID: 12646771
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
    Krauss GL; Bergin A; Kramer RE; Cho YW; Reich SG
    Neurology; 2001 Feb; 56(3):411-2. PubMed ID: 11171914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
    Genton P; Gelisse P
    Neurology; 2001 Sep; 57(6):1144-5. PubMed ID: 11571362
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimyoclonic effect of levetiracetam.
    Genton P; Gélisse P
    Epileptic Disord; 2000 Dec; 2(4):209-12. PubMed ID: 11174151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of spinal myoclonus with levetiracetam.
    Keswani SC; Kossoff EH; Krauss GL; Hagerty C
    J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):457-8. PubMed ID: 12235322
    [No Abstract]   [Full Text] [Related]  

  • 15. Limited efficacy of levetiracetam on myoclonus of different etiologies.
    Lim LL; Ahmed A
    Parkinsonism Relat Disord; 2005 Mar; 11(2):135-7. PubMed ID: 15734675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.
    Kovács T; Farsang M; Vitaszil E; Barsi P; Györke T; Szirmai I; Kamondi A
    J Neural Transm (Vienna); 2009 Dec; 116(12):1631-4. PubMed ID: 19756367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical challenge of posthypoxic myoclonus.
    Frucht SJ
    Adv Neurol; 2002; 89():85-8. PubMed ID: 11968475
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment and long-term follow-up of post-anoxic myoclonus].
    Janszky J; Holló A; Halász P
    Orv Hetil; 2001 Sep; 142(38):2091-3. PubMed ID: 11697066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
    Striano P; Manganelli F; Boccella P; Perretti A; Striano S
    Mov Disord; 2005 Dec; 20(12):1610-4. PubMed ID: 16078205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intention and post-anoxic action myoclonias. Amelioration by piracetam].
    Cremieux C; Serratrice G
    Nouv Presse Med; 1979 Oct; 8(41):3357-8. PubMed ID: 534204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.